Guidelines for the diagnosis and therapy of diabetes mellitus in cystic fibrosis

Current Opinion in Pulmonary Medicine

Volumn 5, Issue 6, 1999, Pages 378-382

  Riggs, Andrew C ^a   Seaquist, Elizabeth R ^a   Moran, Antoinette ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CONSENSUS DEVELOPMENT; CYSTIC FIBROSIS; DIABETES MELLITUS; HUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW;

CONSENSUS DEVELOPMENT CONFERENCES; CYSTIC FIBROSIS; DIABETES MELLITUS; HUMANS; INSULIN; PRACTICE GUIDELINES;

EID: 0033227047     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199911000-00010     Document Type: Article

References (41)

1. Moran A, Hardin D, Rodman D, et al.: Diagnosis, screening, and management of CFRD: a consensus conference report. J Diabetes Res and Clin Pract. In press. In this article, the recommendations of a consensus panel of cystic fibrosis and diabetes experts are presented. The existing literature on pathophysiology and management of CFRD is reviewed, and practical treatment guidelines are offered.
2. FitzSimmons S: The changing epidemiology of cystic fibrosis. J Pediatr 1993, 122:1-9.
3. Cystic Fibrosis Foundation Patient Registry: 1997 annual data report. 1998, Bethesda, Maryland.
4. Rosenecker J, Eichler I, Kuhn L, Harms HK, von der Hardt J: Genetic determination of diabetes mellitus in patients with cystic fibrosis. J Pediatr 1995, 127:441-443.
5. Moran A, Doherty L, Wang X, Thomas W: Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998, 133:10-16. In this article, the pathophysiology of CFRD is reviewed and prevalence figures are provided for children and adults with diabetes and impaired glucose tolerance in a large cystic fibrosis clinic.
6. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, Klein DJ: Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988, 112:373-377.
7. Lanng S, Thorsteinsson B, Nerup J, Koch C: Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatrica 1994, 83:849-853. In this article, evidence is provided to support a cause-and-effect relationship between insulin deficiency and clinical decline in patients with cystic fibrosis.
8. Lanng S, Thorsteinsson B, Nerup J, Koch C: Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992, 151:684-687.
9. American Diabetes Association clinical practice recommendations. Diabetes Care 1998, S1.
10. Stewart AK, Hanna M, Corey J, Zielenski J, Tsui L-C, Durie PB, Pencharz PB, Tullis E: Glucose tolerance in adults with CF: phenotype-genotype corrleations. Pediatric Pulmonology 1997, S14:361A.
11. Moran A, Pyzdrowski K, Weinreb MD, Kahn BB, Smith SA, Adams KL, Seaquist ER: Insulin sensitivity in cystic fibrosis. Diabetes 1994, 43:1020-1026.
12. Holl RW, Heinze E, Wolf A, Rank M, Teller WM: Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycemia in CF. Eur J Pediatr 1995, 154:356-361.
13. Austin A, Kalhan SC, Orenstein D, Nixon P: Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endo Metab 1994, 79:80-85.
14. Hardin DS, LeBlanc A, Lukenbaugh S, Seilheimer DK: Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997, 130:948-956.
15. Lanng S, Thorsteinsson B, Roder ME, Nerup J, Koch C: Insulin sensitivity and insulin clearance in CF patients with normal and diabetic glucose tolerance. Clin Endocrinol 1994, 41:217-223.
16. Lohr M, Goertchem P, Nizze H, Gould NS, GBould VE, Oberholzer M, Heitz PU, Kloppel G: CF associated islet changes may provide a basis tor diabetes. Virchows Archiv A Pathol Anat 1989, 414:179-185.
17. Kopito LE, Schwachman H: The pancreas in CF: chemical composition and comparative morphology. Ped Res 1976, 10:742-749.
18. Iannucci A, Mukai K, Johnson D, Burke B: Endocrine pancreas in cystic fibrosis: an Immunohistochemical study. Hum Pathol 1984, 15:278-284.
19. Couce M, O'Brien TD, Moran A, Roche PC, Butler PC: Diabetes mellitus in CF is characterized by islet amyloidosis. J Clin Endocrinol Metab 1996, 81:1267-1272.
20. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP: Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991, 118:715-723.
21. Lippe BM, Sperling MA, Dooley RR: Pancreatic alpha and beta cell function in cystic fibrosis. J Pediatr 1977, 90:751-755.
22. Lanng S, Thorsteinsson B, Roder ME, Orskov C, Holst J, Nerup J, Koch C: Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinologica 1993, 128:207-214.
23. Cucinotta D, Conti Nibali S, Arrigo T, Di Benedetto A, Magazzu G, Di Cesare E, Constantino A: Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res 1990, 34:33-38.
24. DeSchepper J, Hachimi-Idrissi S, Smitz J, Dab I, Loeb H: First-Phase Insulin Release in Adult Cystic Fibrosis Patients: Correlation with Clinical and Biological Parameters. Horm Res 1992, 38:260-263.
25. Meacham LR, McKean LP, Buchanan CN, Caplan DB, Pfaffle RW, Parks JS, Culler FL: Selective preservation of somatostatin secretion in CF patients with diabetes. Pediatr Pulmonol 1991, (suppl 6):333A.
26. Johnson KH, O'Brien TD, Betsholtz C, Westermark P: Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. N Engl J Med 1989, 321:513-518.
27. Laszik Z, Pap A, Farkas G, Ormos J: Endocrine pancreas in chronic pancreatitis. Arch Pathol Lab Med 1989, 113:47-51.
28. Clark A, Cooper GJS, Lewis CE, Morris JF, Willis AC, Reid KBM, Turner RC: Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet 1987, 2:231-234.
29. Rodman HM, Doershuk CF, Roland JM: The interaction of two diseases: diabetes mellitus and cystic fibrosis. Medicine 1986, 65:389-397.
30. Sullivan MM, Denning CR: Diabetic microanglopathy in patients with cystic fibrosis. Pediatrics 1989, 84:642-646.
31. Lanng S, Thorstoinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C: Diabetes mellitus in Danish CF patients: prevalence and late diabetic complications. Acta Paediatr 1994, 83:72-77.
32. Hardin DS, LeBlanc A, Para L, Seilheimer DK: Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 1999, 48:1082-1087. In this article, defects in glucose and fat use in patients with cystic fibrosis are reviewed.
33. Allen H, Klingensmith GJ, Gay E, Hamman R: Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S. Diabetes Care 1998, 21:943-948.
34. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C: Glucose tolerance in cystic fibrosis: a five year prospective study. BMJ 1995, 311:655-659. In this article, extensive clinical experience with patients with CFRD and impaired glucose tolerance in the Danish cystic fibrosis population is summarized.
35. DeSchepper J, Dab I, Derde MP, Loeb H: Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated hemoglobin determinations. Eur J Pediatr 1991, 150:403-406.
36. De Luca F, Arrigo T, Conti Nibali S, Sferlazzas C, Gigante A, DiCesare E, Cucinotta D: Insulin Secretion, Glycosylated Haemoglobin and Islet Cell Antibodies in Cystic Fibrosis Children and Adolescents with Different Degrees of Glucose Tolerance. Horm Metab Res 1991, 23:495-498.
37. Culler FL, McKean LP, Buchanan CJ, Caplan DB, Meacham LR: Glipizide treatment of patients with CF and impaired glucose tolerance. In: Endocrine Society Program and Abstracts. 1992. San Antonio, Texas 45A.
38. Hinds A, Sheehan AG, Parsons HG: Tobutamide causes a modest increase in insulin secretion in CF patients with impaired glucose tolerance. Metabolism: Clinical and Experimental. 1995, 44:13-18.
39. Horswill CA, Zipf WB, Kien CL, McCoy KS, O'Dorisio T: Glipizide increased insulin secretion but not growth of children with CF. FASEB 1990, 4:3272A.
40. Zipf WB, Kien CL, Horswill CA, McCoy KS, O'Dorisio T, Pinyerd BL: Effects of tolbutamide on growth and body composition of nondiabetic children with CF. Pediatr Res 1991, 30:309-314.
41. Sheppard DJ, Welsh MJ: Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrance conductance regulator chloride currents. J Gen Physiol 1992, 100:573-591.